On July 31, medical artificial intelligence (AI) company Lunit announced plans to develop a personalized AI-based integrated ...

Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States ...

Q2 2025 Management View Kevin Sayer, CEO, announced "second quarter organic revenue growth of 15% compared to the second quarter of 2024," attributing strong performance to "focused execution by our ...

WASHINGTON (AP) — The Trump administration is pushing an initiative for millions of Americans to upload personal health data ...

Cardiosense has received U.S. Food & Drug Administration clearance for a wearable sensor that can measure multiple cardiac ...

Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...

The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.

PainChek, EMVision and Clever Culture Systems are among ASX health companies reporting quarterly results today.

A new technology that harnesses artificial intelligence (AI) to analyze mammograms and improve the accuracy of predicting a ...

In this week’s edition of InnovationRx, we look at Halle Berry’s menopause startup, Ambience Healthcare’s $243 million ...

On July 22, 2025, Morgan Stanley maintained its ‘Buy’ rating on JAZZ. However, the analyst lowered its price target slightly ...

Medical AI company Cardiosense has claimed an FDA clearance for its CardioTag device, a wearable sensor that provides a ...